Rhythmia HDx™

EGM Out to Signal Station Cable (Stockert™)

Registry build 21.09.26
10manufacturers in China registered for this device type
26catalogue numbers in this listing
15510(k) clearances naming this product code
24recalls on this code

Who Else Makes It

Concentrated in Guangdong (7), Shanghai (2), Jiangsu (1). 4 of them are registered as contract manufacturers, able to build to a buyer’s own specification.

Chinese manufacturers registered for FDA product code DQK
Manufacturer City Province Registered as Device types
Amphenol Medical Technologies (Dongguan) Co., Ltd. Dongguan Guangdong Contract manufacturer 77
Jabil Circuit (Shanghai) Ltd. Shanghai Shanghai Contract manufacturer 31
Amphenol Alden Products Company Shenzhen Guangdong Contract manufacturer 24
Dongguan Ergotron Precision Technology Co., Ltd. Dongguan Guangdong Contract manufacturer 2
Shenzhen Mindray BIO-Medical Electronics Co., Ltd. Shenzhen Guangdong Specification developer 61
GE Medical Systems (China) Co., Ltd. Wuxi Jiangsu Contract manufacturer 57
Edan Instruments, Inc. Shenzhen Guangdong Contract manufacturer 56
Shenzhen BelterHealthMeasurementAndAnalysisTechnologyCo.,Ltd Shenzhen Guangdong Manufacturer 7
Philips (China) Investment Co., Ltd. Philips Healthcare – Shanghai CDC Shanghai Shanghai Specification developer 6
Shenzhen Carewell Electronics Co., Ltd. Shenzhen Guangdong Manufacturer 2

Record

Regulatory record for Rhythmia HDx™
Listed by Boston Scientific Corporation, United States
FDA product code DQK
Device type Computer, Diagnostic, Programmable
Device class Class 2
Regulation 21 CFR 870.1425
Establishment Specification developer, Repacker / relabeller, Complaint-file establishment, Manufacturer, Exporter
Record published 2019-04-24
Record revised 2024-10-02 (version 5)

Specifications

Specifications
MRI safety Labeling does not contain MRI Safety Information
Prescription Prescription only
Supplied as a kit Yes
Label carries lot or batch number, manufacturing date, serial number

Catalogue Numbers

Catalogue numbers for Rhythmia HDx™
Catalogue number Size Status
M004RA64030 In distribution
M004RAMMTIPS220 In distribution
M004RH11220 In distribution
M004RH1020H0 In distribution
M004RA5010A0 In distribution
M004RH1020R0 In distribution
M004RALRCBL20 In distribution
M004RH14510 In distribution
M004RA60020 In distribution
M004RA9000ECG60 In distribution
M004RBEVAL2END0 In distribution
M004RA9000ICAB60 In distribution
M004RA61030 In distribution
M004RH20010 In distribution
M004RA9100ECG60 In distribution
M004RH20020 In distribution
M004RBINSTALL2EN0 In distribution
M004RH15010 In distribution
M004RH40100 In distribution
M004RA9100IC60 In distribution
M004RA9100ECG30 In distribution
M004RBINSTALL2ENR0 In distribution
M004RH10200 In distribution
M004RH11120 In distribution
M004RA9100IC30 In distribution
M004RA61020 In distribution

Same Product Code

Other products under the same FDA product code
Product Sold by Catalogue numbers
EnSite™ St. Jude Medical 177
Computer, Diagnostic, Programmable St. Jude Medical 57
MediGuide™ St. Jude Medical 41
AcQMap Acutus Medical, Inc. 38
WorkMate Claris™ St. Jude Medical 35
iLab Ultrasound Imaging System Boston Scientific Corporation 32
Rhythmia™ Mapping System Boston Scientific Corporation 31
Sentinel Spacelabs Healthcare (Washington), Inc 28
EnSite Precision™ St. Jude Medical 23
PathfinderSL Spacelabs Healthcare (Washington), Inc 22
Labsystem™ PRO Boston Scientific Corporation 19
Pathfinder SL Spacelabs Healthcare (Washington), Inc 16

Showing 12 of 228. All products under Computer, Diagnostic, Programmable

510(K) Clearances

FDA 510(k) clearances naming this product code
Clearance Decision date
K253692 2026-08-21
K251344 2025-05-28
K241227 2024-08-29
K230884 2023-09-26
K212490 2021-10-20
K210889 2021-06-25
K201713 2020-07-23
K201178 2020-05-29
K192438 2019-11-27
K191008 2019-07-02
K173837 2018-07-25
K162793 2017-03-10
K151613 2015-10-06
K141185 2014-06-06
K003362 2001-03-01

Recalls

23 of these are Class II. Class II means a temporary or reversible health consequence. Volume alone is not a quality signal: a manufacturer that ships more recalls more.

Recalls referencing this product code
Initiated FDA class Root cause Reason Quantity Closed
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 4 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 14 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 15 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 5 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 5 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 161 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 2 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 2 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 197 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 1 unit
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 5 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 1 unit
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 9 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 9 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 6 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 58 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 8 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 31 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 92 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 1 unit
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 124 units
2024-09-05 Class II Under Investigation by firm Boston Scientific has received reports indicating the grid mark overlay on the cross-sectional view did not present correctly when an OptiCross 18 Peripheral Imaging Catheter was connected to the AVVIGO+ Multi-Modality Guidance System while 40 units
2019-09-18 Class II Other Certain iLab Polaris Systems which were upgraded with a previous 2.10 software version (disk batch 629774) contained a bug in which only the True Color Secondary Capture (SC) format will archive Diastolic Hyperemia-Free Ratio data as intend 150 units
2005-03-14 Not classified Other The device has the potential for overheating its transformer and has the potential for fire hazard. 69 units distributed worldwide 2005-12-13

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

Where China Actually Supplies

Every device page names the company that lists it and the factories registered to make the same thing. These are the sections with the most of them.

5,100manufacturers registered in China
2,581device types they are registered for
340,248device records, each naming its maker
31provinces with a registered manufacturer